Health Equity & Access Weekly Roundup: June 5, 2026
• Federal initiatives have expanded a drug-price transparency tool and proposed a $50 per month access plan for eligible Medicare beneficiaries using GLP-1 medications. • The new pricing proposal is scheduled to take effect in July 2026, though debates continue regarding actual savings and remaining affordability gaps. • The weekly roundup also highlights critical health equity issues, including cancer trauma, abortion cost disparities, and the economic impact of food insecurity.
ajmc.com

-copy.jpeg%3Fwidth%3D1200%26height%3D800%26crop%3D1200%3A800&w=1920&q=85)